Skip to main content
TISSUE REGENIX GROUP PLC logo

TISSUE REGENIX GROUP PLC — Investor Relations & Filings

Ticker · TRX ISIN · GB00BNTXR104 LEI · 213800PNOD5UHQUFJI36 IL Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2022-07-18 Major Shareholding Noti…
Country GB United Kingdom
Listing IL TRX

About TISSUE REGENIX GROUP PLC

https://www.tissueregenix.com/

Tissue Regenix Group PLC is a medical technology company specializing in regenerative medicine. The company develops and commercializes biological products designed to repair and regenerate human tissue. It employs proprietary decellularization platform technologies to process human and animal tissues, creating acellular scaffolds. When implanted, these scaffolds support the patient's own cells in repopulating and regenerating the damaged area. The company's portfolio serves three main clinical areas: biosurgery for complex wound care, orthopaedics for sports medicine and bone graft substitutes, and dental applications for tissue and bone repair. Key products include DermaPure®, OrthoPure® XT, and the Matrix® line of bone graft substitutes.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with "RNS Number" and contains a standard form titled "TR-1: Standard form for notification of major holdings." This form details changes in voting rights held by a shareholder ("The Diverse Income Trust plc"), indicating a transaction that crosses or reaches a notification threshold. This type of regulatory filing concerning changes in significant share ownership perfectly matches the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a major holding notification, not a general announcement (RNS) or a proxy solicitation (PSI).
2022-07-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with "RNS Number : 8498S" and contains the header "National Storage Mechanism". The content details a "TR-1: Standard form for notification of major holdings" regarding an acquisition of voting rights by Harwood Capital Management (Gibraltar) Limited, crossing a threshold (from 14.04% to 18.08%). This type of mandatory disclosure regarding significant changes in share ownership is classified as a Major Shareholding Notification (MRQ) in the provided schema. Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-07-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 7128S' and contains the standard footer information indicating it is provided by RNS, the news service of the London Stock Exchange, which is approved by the FCA. The content itself is a 'TR-1: Standard form for notification of major holdings' detailing an acquisition or disposal of voting rights by 'Premier Miton Group plc' in 'TISSUE REGENIX GROUP PLC'. This type of mandatory disclosure regarding changes in significant share ownership thresholds fits the definition of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific category.
2022-07-15 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is identified by the header 'RNS Number : 3671Q' and contains the standard form 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-06-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is filed under 'RNS Number : 3208Q' by Tissue Regenix Group PLC. It details an acquisition or disposal of voting rights by LOIM Lombard Odier Asset Management (Europe) Limited, showing a change in shareholding percentage from 13.98% to 10.90%. This type of filing, which reports changes in significant share ownership thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2022-06-27 English
Exercise of Options and Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content announces the exercise of options resulting in new share issuance and provides the resulting 'Total Voting Rights'. This type of mandatory, immediate disclosure to the market, especially concerning share capital changes and voting rights, fits best under the general 'Regulatory Filings' category (RNS) as it is not a specific report like 10-K, ER, or IR, nor is it a director's dealing (DIRS) or a capital raising announcement (CAP) in the traditional sense, but rather a mandatory notification regarding share structure changes. Given the options, RNS (Regulatory Filings) is the most appropriate general classification for this type of LSE announcement that doesn't fit a more specific category like DIRS or SHA, although it touches upon share changes.
2022-06-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.